Spontaneous bleeding and poor bleeding response with extended half‐life factor IX products: A survey of select US haemophilia treatment centres-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Spontaneous bleeding and poor bleeding response with extended half‐life factor IX products: A survey of select US haemophilia treatment centres

Published:2020-03-06 Issue:3 Volume:26 Page:
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Malec Lynn M.¹²^ORCID,Croteau Stacy E.³^ORCID,Callaghan Michael U.⁴^ORCID,Sidonio Robert F.⁵

Affiliation:

1. Versiti Blood Research Institute Milwaukee Wisconsin

2. Medical College of Wisconsin Milwaukee Wisconsin

3. Children's Hospital of Boston Boston Massachusetts

4. Children's Hospital of Michigan Detroit Michigan

5. Children's Healthcare of Atlanta Atlanta Georgia

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.13943

Reference8 articles.

1. Circulating and binding characteristics of wild-type factor IX and certain Gla domain mutants in vivo

2. In vivo evidence of intravascular binding sites for coagulation factor IX

3. Identification of the endothelial cell binding site for factor IX.

4. Abnormal hemostasis in a knock-in mouse carrying a variant of factorÂ IX with impaired binding to collagen typeÂ IV

5. Enhanced pharmacokinetic properties of a glycoPEGylated recombinant factor IX: a first human dose trial in patients with hemophilia B

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant factor IX Fc for the treatment of hemophilia B;European Journal of Haematology;2024-02-18

2. Biodistribution of recombinant factor IX, extended half-life recombinant factor IX Fc fusion protein, and glycoPEGylated recombinant factor IX in hemophilia B mice;Blood Coagulation & Fibrinolysis;2023-07-17

3. Extended half-life factor IX prophylaxis up to every 21 days in hemophilia B: a longitudinal analysis of the efficacy and safety in selected adult patients;Research and Practice in Thrombosis and Haemostasis;2023-05

4. Albumin-Fusion Recombinant FIX in the Management of People with Hemophilia B: An Evidence-Based Review;Drug Design, Development and Therapy;2022-09

5. IDELVION: A Comprehensive Review of Clinical Trial and Real-World Data;Journal of Clinical Medicine;2022-02-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3